The median OS of female HCC patients with a non-altered JAK–STAT signaling pathway (n = 55) was 95 months, whereas patients with an altered JAK–STAT signaling pathway (n = 11) had a median OS of 23 months (P = 0.0178; log-rank test). The gene discussed is SOAT1; the disease is hepatocellular carcinoma.